Oncology PracticeCircumcision May Lower Prostate Cancer RiskMarch 12, 2012Genitourinary CancerPreventive Care
Oncology PracticeVEGF-Targeting Cancer Drugs Raise Risk of Fatal Side EffectsFebruary 24, 2012Breast CancerGastroenterologyGenitourinary CancerLung CancerMelanomaGastrointestinal Cancer
Oncology PracticeFDA Tracks Fake Avastin to Foreign Supply Distributed in U.S.February 21, 2012Genitourinary CancerLung CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeVitamin E Supplements Linked to Increase in Prostate Cancer RiskFebruary 16, 2012Genitourinary Cancer
Oncology PracticeCosts Don't Always Match Outcomes of Prostate Cancer TreatmentsFebruary 15, 2012Genitourinary Cancer
Oncology PracticeEverolimus Shrinks Angiomyolipomas from Tuberous Sclerosis ComplexFebruary 13, 2012Genitourinary Cancer
Oncology PracticeMild CKD Ups Risks of Renal, Urothelial CancersFebruary 10, 2012Genitourinary Cancer
Oncology PracticeFDA Panel Rejects Denosumab Against Bone Metastasis in Prostate CancerFebruary 8, 2012Genitourinary Cancer
Oncology PracticeFDA Questions Earlier Denosumab Use in Prostate CancerFebruary 7, 2012Genitourinary Cancer
Oncology PracticeKidney Cancer Patients May Need Higher Axitinib DoseFebruary 7, 2012Genitourinary Cancer
Oncology PracticeALSYMPCA Trial: Radium-223 Prolongs Life in Some Prostate CancersFebruary 6, 2012Genitourinary Cancer
Oncology PracticeMDV3100 Cuts Risk of Death in Advanced Prostate CancerFebruary 3, 2012Genitourinary Cancer
The Journal of Community and Supportive OncologyMaximizing clinical outcomes with axitinib therapy in advanced renal cell carcinoma through proactive side-effect managementFebruary 1, 2012Genitourinary Cancer
The Journal of Community and Supportive OncologySynchronous presentation of advanced rectal and intermediate-risk prostate cancers: a multidisciplinary approachFebruary 1, 2012Genitourinary Cancer
